![Robert Michael Savel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Michael Savel
Geen lopende functies
Profiel
Robert Michael Savel formerly worked at Johnson & Johnson, as Vice President-Quality & Compliance from 1999 to 2007, Inspire Pharmaceuticals, Inc., as Chief Technical Officer & Senior Vice President from 2010 to 2011, Optimer Pharmaceuticals LLC, as Senior VP-Operations & General Manager from 2012 to 2013, PDL BioPharma, Inc., as Senior Vice President-Technical Operations from 2007 to 2008, Otonomy, Inc., as Chief Technical Officer from 2014 to 2022, and Savel Enterprises LLC, as President from 2008 to 2010.
Mr. Savel received his undergraduate degree from Virginia Polytechnic Institute & State University.
Eerdere bekende functies van Robert Michael Savel
Bedrijven | Functie | Einde |
---|---|---|
OTONOMY | Hoofd Techniek/Wetenschap/O&O | 15-08-2022 |
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | 01-12-2013 |
Inspire Pharmaceuticals, Inc.
![]() Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 |
Savel Enterprises LLC | President | 01-09-2010 |
PDL BIOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2008 |
Opleiding van Robert Michael Savel
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Inspire Pharmaceuticals, Inc.
![]() Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
PDL BioPharma, Inc.
![]() PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Otonomy, Inc.
![]() Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Savel Enterprises LLC |